The US Food & Drug Administration has been very clear that its inspectional activity has been significantly disrupted by the COVID-19 pandemic. Now there are numbers to show just how dramatic the impact has been, thanks to a report from the US Government Accountability Office.
GAO found that FDA conducted only about 13% of the domestic inspections during the period from March to October 1,2020...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?